Factors Associated with Poor Glycemic Control among Patients with Type 2 Diabetes Mellitus in Ambo Hospital, Ambo; Ethiopia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Poor and inadequate glycemic control among patients with type 2 diabetes constitutes a major public health problem and major risk factor for the development of diabetes complications. Therefore, the purpose of this study was to determine factors associated with poor glycemic control among type 2 diabetes patients attending Ambo hospital chronic care service. Methods: A prospective cross sectional study was conducted. A 5% sample pretest was performed on randomly selected patients before the beginning of the study. A three month consecutive measurements of blood glucose was used to assess glycemic control. Results: A total of 102 type 2 diabetes patients were interviewed and their chart was checked using a structured check list format. Of the total 102 patients, 50% had a mean FBG level of > 126 mg/dl with three month consecutive measurement resulting in poor glycemic control. We have identified that patients with age in between 51-50 yr (p=0.038) and age 61-70 yr (p=.017) were poorly managed their blood glucose level compared to the other age groups under study. The most frequent comorbidity observed over type 2 diabetes was hypertension 41(40.6%) followed by renal disease and dyspepsia with 5 and 3 patients respectively. Furthermore, patients who had hyperlipidemia and peripheral neuropathy as a comorbidities had 5 and 579 more prone to develop poor blood glucose control compared to patients with no comorbidities with 95% C.I of (1.145-20.462 and 116.8-2870), respectively. Conclusion: The proportion of patients with poor glycemic control was high, which was nearly comparable to that reported from many countries. Age in between 51-70 yr and the presence of comorbidities like hyperlipidemia and peripheral neuropathy were associated with poor glycemic control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Factors associated with poor glycemic control among patients with type 2 diabetes
Khattab, M., Khader, Y. S., Al-Khawaldeh, A., & Ajlouni, K. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.12.008 · Cited by 507 · cited 1×
“This result was in line with other studies conducting using HbA1C as measurement of glycemic control [15-17].”
ResultPoor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude
WALLACE, T. M. (2000) · QJM · doi:10.1093/qjmed/93.6.369 · Cited by 166 · cited 1×
“In clinical practice, optimal glycemic control is difficult to obtain on a long-term basis because the reasons for poor glycemic control in T2DM are complex [5] Both patient and health care provider-related factors may contribute to poor glycemic control [6,7].”
Background
Cited by
Tekalegn, Y., Addissie, A., Kebede, T., & Ayele, W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193442 · Cited by 101
Glycemic control among diabetic patients in Ethiopia: A systematic review and meta-analysis
Gebreyohannes, E. A., Netere, A. K., & Belachew, S. A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0221790 · Cited by 84
Nigussie, S., Birhan, N., Amare, F., Mengistu, G., Adem, F., & Abegaz, T. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0251506 · Cited by 62
“The proportion of poor glycemic control was comparable to the results reported in Ambo, Brazil, Iran, and Jordan [11, 17, 31, 32].”
MethodResultBitew, Z. W., Alemu, A., Jember, D. A., Tadesse, E., Getaneh, F. B., Seid, A., & Weldeyonnes, M. (2023) · INQUIRY: The Journal of Health Care Organization, Provision, and Financing · doi:10.1177/00469580231155716 · Cited by 58
Mideksa, S., Ambachew, S., Biadgo, B., & Baynes, H. W. (2018) · Adipocyte · doi:10.1080/21623945.2018.1467716 · Cited by 30
Metadata
- Authors
- Alebachew Woldu, M., & Diriba Wami, C.
- Venue
- Endocrinology & Metabolic Syndrome
- Publisher
- OMICS Publishing Group
- Published
- 2014
- Volume
- 03
- Issue
- 04
- ISSN
- 2161-1017 (ISSN-L)
- OpenAlex
- W2555067354
- Cited by
- 43
- References
- 2
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.